Back to top
more

Vanguard Consumer Discretionary Index Fund ETF Shares: (VCR)

(Delayed Data from NYSE) As of Jun 9, 2026 03:36 PM ET

$387.80 USD

387.8
38,024

+1.81 (0.47%)

Volume: 38,024

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

4 - Sell of 5       4  

After-Market: $388.46 +0.66 (0.17 %) 7:58 PM ET

Zacks News

Sweta Jaiswal, FRM headshot

ETFs at Risk as U.S. Consumer Confidence Slips to Six-Year Low

It is being believed that given the uncertainty surrounding the coronavirus pandemic and another round of federal stimulus package, consumer spending might not rise in the near term at least.

Sweta Jaiswal, FRM headshot

Will ETFs Gain on Steady U.S. Consumer Sentiment in August?

Let's look at the impact of stable U.S. consumer sentiment data on the consumer discretionary sector, which attracts a major portion of consumer spending.

Sweta Jaiswal, FRM headshot

ETFs at Risk as U.S. Consumer Confidence Takes a Hit in July

It is being believed that given the uncertainty surrounding the coronavirus pandemic, consumer spending might not rise in the near term at least.

Sweta Jaiswal, FRM headshot

Starbucks' Q3 Earnings Top Amid Coronavirus Crisis: ETFs to Gain

Starbucks' Q3 earnings release has been cheered by investors on better-than-expected earnings results despite the coronavirus crisis.

Sweta Killa headshot

Amazon Posts Biggest Profits in 26 Years: 5 ETFs to Buy

Amazon posted the biggest profit in its 26-year history buoyed by a massive boost from the accelerated adoption of e-commerce amid the COVID-19 pandemic.

Sweta Jaiswal, FRM headshot

Starbucks to Report Q3 Earnings: ETFs in Focus

Starbucks' third-quarter fiscal 2020 results are expected to reflect impact of the coronavirus pandemic.

Sweta Jaiswal, FRM headshot

Will Coronavirus Vaccine Optimism Drive These ETFs?

The coronavirus vaccine progress has brought back optimism for some ETFs, largely affected by the outbreak-led slowdown in economic activities.